Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Multiple FNH-Like Lesions in a Patient with Chronic Budd-Chiari Syndrome: Gd-EOB-Enhanced MRI and BR1 CEUS Findings.

Newerla C, Schaeffer F, Terracciano L, Hohmann J.

Case Rep Radiol. 2012;2012:685486. doi: 10.1155/2012/685486. Epub 2012 Mar 11.

2.

Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US.

Sugimori K, Numata K, Okada M, Nihonmatsu H, Takebayashi S, Maeda S, Nakano M, Tanaka K.

J Med Ultrason (2001). 2017 Jan;44(1):89-100. doi: 10.1007/s10396-016-0750-9. Epub 2016 Oct 22.

PMID:
27771842
3.

Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.

Tateyama A, Fukukura Y, Takumi K, Shindo T, Kumagae Y, Kamimura K, Nakajo M.

World J Gastroenterol. 2012 Nov 21;18(43):6269-76. doi: 10.3748/wjg.v18.i43.6269.

4.

Large regenerative nodules in a patient with Budd-Chiari syndrome after TIPS positioning while on the liver transplantation list diagnosed by Gd-EOB-DTPA MRI.

Renzulli M, Lucidi V, Mosconi C, Quarneti C, Giampalma E, Golfieri R.

Hepatobiliary Pancreat Dis Int. 2011 Aug;10(4):439-42.

PMID:
21813396
5.

Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas.

Campos JT, Sirlin CB, Choi JY.

Insights Imaging. 2012 Oct;3(5):451-74. doi: 10.1007/s13244-012-0179-7. Epub 2012 Jun 15.

6.

Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.

Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO.

Invest Radiol. 2008 Jul;43(7):504-11. doi: 10.1097/RLI.0b013e3181705cd1.

PMID:
18580333
7.

Improved diagnosis of well-differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid-enhanced magnetic resonance imaging and Sonazoid contrast-enhanced ultrasonography.

Kawada N, Ohkawa K, Tanaka S, Matsunaga T, Uehara H, Ioka T, Takano Y, Takakura R, Imanaka K, Tamai C, Kawaguchi T, Tomita Y, Nakanishi K, Katayama K.

Hepatol Res. 2010 Sep;40(9):930-6. doi: 10.1111/j.1872-034X.2010.00697.x.

PMID:
20887598
8.

Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI.

Haimerl M, W├Ąchtler M, Zeman F, Verloh N, Platzek I, Schreyer AG, Stroszczynski C, Wiggermann P.

PLoS One. 2014 Jun 20;9(6):e100315. doi: 10.1371/journal.pone.0100315. eCollection 2014.

9.

Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.

Iwamoto T, Imai Y, Kogita S, Igura T, Sawai Y, Fukuda K, Yamaguchi Y, Matsumoto Y, Nakahara M, Morimoto O, Seki Y, Ohashi H, Fujita N, Kudo M, Takehara T.

Dig Dis. 2016;34(6):679-686. Epub 2016 Oct 17.

PMID:
27750237
10.

Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.

Ohama H, Imai Y, Nakashima O, Kogita S, Takamura M, Hori M, Seki Y, Sawai Y, Igura T, Fukuda K, Makino Y, Morimoto O, Ohsawa M, Sakamoto M, Murakami T.

J Gastroenterol. 2014 Jun;49(6):1081-93. doi: 10.1007/s00535-013-0859-1. Epub 2013 Aug 1.

PMID:
23903870
11.

[Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].

Portilha MA, Pedro MT, Ruivo C, Semedo LC, Marques C, Alves FC.

Acta Med Port. 2011 Dec;24 Suppl 2:531-8. Epub 2011 Dec 31. Portuguese.

12.

The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis.

Suh CH, Kim KW, Kim GY, Shin YM, Kim PN, Park SH.

Eur Radiol. 2015 Apr;25(4):950-60. doi: 10.1007/s00330-014-3499-9. Epub 2014 Dec 24. Review.

PMID:
25537979
13.

Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.

Golfieri R, Garzillo G, Ascanio S, Renzulli M.

Dig Dis. 2014;32(6):696-704. doi: 10.1159/000368002. Epub 2014 Oct 29. Review.

PMID:
25376286
14.

Imaging of focal nodular hyperplastic-like nodules in alcoholic liver cirrhosis patients using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging.

Miyaaki H, Ichikawa T, Taura N, Miuma S, Kawaguchi M, Kohno R, Isomoto H, Takeshima F, Nakashima O, Nakao K.

Clin J Gastroenterol. 2011 Aug;4(4):266-72. doi: 10.1007/s12328-011-0244-7. Epub 2011 Jul 14.

PMID:
26189532
15.

Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.

Kim JW, Lee CH, Kim SB, Park BN, Park YS, Lee J, Park CM.

J Magn Reson Imaging. 2017 Jun;45(6):1599-1608. doi: 10.1002/jmri.25493. Epub 2016 Oct 11.

PMID:
27726242
16.

Focal nodular hyperplasia-like nodule with reduced expression of organic anion transporter 1B3 in alcoholic liver cirrhosis.

Doi N, Tomiyama Y, Kawase T, Nishina S, Yoshioka N, Hara Y, Yoshida K, Korenaga K, Korenaga M, Moriya T, Urakami A, Nakashima O, Kojiro M, Hino K.

Intern Med. 2011;50(11):1193-9. Epub 2011 Jun 1.

17.

A case of idiopathic portal hypertension associated with nodular regenerative hyperplasia-like nodule of the liver and mixed connective tissue disease.

Hayano S, Naganuma A, Okano Y, Suzuki Y, Shiina K, Yoshida H, Hayashi E, Uehara S, Hoshino T, Miyamae N, Kudo T, Ishihara H, Ogawa A, Sato K, Kakizaki S.

Nihon Shokakibyo Gakkai Zasshi. 2016 May;113(5):828-36. doi: 10.11405/nisshoshi.113.828.

PMID:
27151480
18.

A case of Budd-Chiari syndrome: Gd-EOB-DTPA-enhanced MR findings.

Kitajima K, Yoshikawa T, Seo Y, Ohno Y, Yano Y, Miki A, Kanda T, Kanata N, Azuma T, Sugimura K.

Magn Reson Imaging. 2011 May;29(4):579-83. doi: 10.1016/j.mri.2010.10.013. Epub 2011 Jan 8.

PMID:
21216550
19.

Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.

Toyoda H, Kumada T, Tada T, Sone Y, Maeda A, Kaneoka Y.

Hepatol Int. 2015 Jan;9(1):84-92. doi: 10.1007/s12072-014-9553-5. Epub 2014 Jul 23.

PMID:
25788383
20.

Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study.

Granito A, Galassi M, Piscaglia F, Romanini L, Lucidi V, Renzulli M, Borghi A, Grazioli L, Golfieri R, Bolondi L.

Aliment Pharmacol Ther. 2013 Feb;37(3):355-63. doi: 10.1111/apt.12166. Epub 2012 Dec 2.

Supplemental Content

Support Center